Medetomidine is a potent sedative used in the veterinary sector that has also been detected in the illicit drug supply. This guide looks at the drug in more detail and explores why it has raised serious public health concerns in recent years.
What is Medetomidine?
Medetomidine is a synthetic drug used in veterinary medicine to provide sedation, pain relief and muscle relaxation in animals. It stimulates alpha-2 receptors in the brain and central nervous system, which then decreases the release of a neurotransmitter responsible for alertness, heart rate and blood pressure regulation.
Medetomidine is a sedative and not an opioid. It’s closely related to dexmedetomidine, which is used under strict clinical supervision in human intensive care.
Why is Medetomidine Appearing in Drug Supplies?
Increasingly, medetomidine (a veterinary sedative drug) is being used in street drug supplies, most notably alongside fentanyl, heroin and synthetic opioids. However, because most people purchasing illicit drugs are rarely aware of these additives, exposure to such drugs is almost always unintentional.
It’s not clear why drugs are mixed, but it may be because suppliers use sedatives to bulk out products or to increase the sedating effects of short-acting opioids. One thing’s for sure, you cannot confidently identify what a drug actually contains by its appearance, smell or taste alone. This makes the act of taking drugs even more risky, including the medetomidine risks.
What Do We Know About Medetomidine in the UK?
While much of the research comes from the US, public health agencies in the UK are monitoring the drug closely. In 2026, Public Health Scotland issued an alert following the first confirmed detection of medetomidine in Scottish drug samples. There have also been separate reviews published across the UK highlighting increased detections of non-opioid sedatives in illicit drug samples.
Despite this, medetomidine doesn’t currently represent a widespread UK epidemic. However, healthcare workers and community drug services are working together to provide more resources and information to the public on how to stay safe.
What are the health risks?
Medetomidine carries huge physical risks. It can induce deep and unresponsive sedation that lasts much longer than typical opioid effects. It can also cause dangerously slow heart rates and severe low blood pressure. When combined with opioids or other central nervous system depressants, the risk of severe respiratory depression and fatal collapse is extreme.
Medetomidine and Naloxone: Does Naloxone Work Against Medetomidine?
Naloxone doesn’t reverse the effects of medetomidine because medetomidine doesn’t bind to opioid receptors. However, if an overdose is suspected, you should always give naloxone. This is because medetomidine is almost always mixed with illicit opioids, so administering naloxone will reverse the opioid component of the overdose, which can restore breathing and save lives.
If you do suspect an overdose, call 999 immediately.
Warning Signs That Need Emergency Help
Some of the signs of overdose to look out for include:
- Unconsciousness or inability to wake the person up
- Dangerously slow, shallow or absent breathing
- Blue, grey, or pale skin, lips or fingernails
- Seizures, collapse or an abnormally slow pulse
It’s important that you call 999 immediately if you notice any of these signs and tell the operator everything you know about what substances have been taken.
Can Medetomidine Cause Withdrawal?
Repeated exposure to medetomidine can result in physical dependence as well as withdrawal symptoms. Research shows that medetomidine withdrawal can also be very different from standard opioid withdrawal.
Symptoms of medetomidine withdrawal may include:
- Severe and unmanageable agitation and anxiety
- Rapid heart rate and spike in blood pressure
- Persistent tremors and muscle spasms
- Severe nausea and intractable vomiting
Because medetomidine withdrawal directly links to cardiovascular stability and autonomic nervous system regulation, it requires urgent medical help. Standard at-home detox protocols are not suitable.
This is one reason why inpatient rehab is so beneficial. A medically supported detox ensures patient safety at all times. Medication is prescribed to reduce side effects and ensure you are comfortable, and you will be supported and monitored by a medical professional at all times. Not just that, but any questions will be answered and concerns put at ease. Trying to detox on your own is not only very challenging but risky, and it is not recommended.
Treatment and Recovery Support
Overcoming substance use requires dedication, patience and support. When it comes to medetomidine, a structured approach is best with guidance from medical professionals. First, withdrawal must take place with symptoms managed effectively and safely. Then a full evaluation of physical and mental health is required. Once medical stability is achieved, treatment can begin.
Attending residential rehab or community drug services is best, as it provides access to therapy, relapse prevention and behavioural support. Harm reduction and aftercare are also key, which is where local drug services can help.
How Addiction Advocates Can Help
Navigating treatment options can feel overwhelming, but that’s where we come in. Our confidential rehabilitation helpline and referral service helps individuals and families find suitable care, get their questions answered and feel supported from the moment they get in touch.
Our experienced advisors will guide you towards the right rehab centre – tailored to your needs, goals and personal circumstances. We’ll also conduct a thorough medical and clinical assessment to determine which facility is suitable and make sure that every need and requirement is met.
Not just that, but we’re able to help with interventions and can guide you through any challenging conversations you may have with family and friends. You can also relax knowing that you won’t be judged. Our team is here to help you.
Taking the First Step
If you or someone you care about is concerned about drug use and seeking support for addiction, help is available. Contact the team at Addiction Advocates to speak with an advisor in confidence and explore available treatment. The first step towards your new future starts here. So why don’t you pick up the phone or send a confidential message to our team? We’ve helped hundreds of people just like you, and you could be next.
References
- [1] medetomidine - https://www.gov.uk/government/publications/use-and-harms-of-xylazine-medetomidine-and-detomidine/amendment-to-acmd-report-use-and-harms-of-xylazine-medetomidine-and-detomidine-21-october-2025-accessible
- [2] Public Health Scotland - https://publichealthscotland.scot/publications/rapid-action-drug-alerts-and-response-radar-alert-new-xylazine-type-drug-medetomidine/
- [3] medetomidine - https://www.cdc.gov/overdose-prevention/situation-summary/medetomidine.html
- [4] Naloxone - https://www.gov.uk/guidance/supplying-take-home-naloxone-without-a-prescription